|
2009 Conference Publication RNA interference for the treatment of cervical cancers: Solving the delivery and efficacy issuesGu, W. Y., Leggatt, G., Payne, E., Wilson, D., Choyce, A. and McMillan, N. A. J. (2009). RNA interference for the treatment of cervical cancers: Solving the delivery and efficacy issues. 6th Meeting of the Australasian Gene Therapy Society, Sydney, Australia, 29 April - 01 May 2009. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/jgm.1375 |
|
2003 Conference Publication Immunotherapy for HPV associated pre-cancerFrazer, Ian H., Leggatt, G. J., Matsumoto, K., De Kluyver, R., Quinn, M., Nicklin, J., Tan, J., Perrin, L., Ng, P., O'Connor, V., White, O., Wendt, N., Martin, J., Mitchelll, S.V., McKenzie, A., Crowley, J., Edwards, S. and Maher, D. (2003). Immunotherapy for HPV associated pre-cancer. Cancer Vaccine Collaborative 2002, Multiple locations, September 30 - October 1 2002. The Academy of Cancer Immunology. |
|
2001 Conference Publication Mucosal and systemic immunization with BPVL1E7VLP vaccine induce effective cellular immunitySaito, J., Kanzaki, H., Leggatt, G. and Frazer, I. (2001). Mucosal and systemic immunization with BPVL1E7VLP vaccine induce effective cellular immunity. 53rd Annual Congress of the Japan Society of Obstetrics and Gynecology, Sapporo, Japan, 12-15 May 2001. 40128 BOLOGNA: Medimond S R L. |
|
1995 Conference Publication Similar presentation of a promiscuous HIV 1 peptide by human and murine class I MHC molecules, and ability of peptide induced murine CTL to clear virus infection in scid miceAlexander-Miller, M. A., Parker, K. C., Leggatt, G. R., Tsukui, T., Pendleton, C. D., Coligan, J. E. and Berzofsky, J. A. (1995). Similar presentation of a promiscuous HIV 1 peptide by human and murine class I MHC molecules, and ability of peptide induced murine CTL to clear virus infection in scid mice. -, -, -. LARCHMONT: MARY ANN LIEBERT INC PUBL. |
